Navigation Links
MEI Pharma Announces Pricing of Public Offering of Common Stock
Date:10/25/2013

SAN DIEGO, Oct. 25, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has priced an underwritten public offering of 4,375,000 shares of its common stock at an offering price of $8.00 per share, for total gross proceeds (before underwriting discount and commissions and estimated expenses) of approximately $35 million. The Company has granted the underwriters a 30-day option to purchase up to 656,250 additional shares of its common stock to cover over-allotments, if any. The offering is expected to close on October 30, 2013, subject to customary closing conditions.

(Logo: http://photos.prnewswire.com/prnh/20120628/LA32362LOGO)

The Company plans to use the net proceeds of the offering, together with other available funds, to progress the clinical development programs for its drug candidates, Pracinostat, ME-344 and PWT143, and for other general corporate purposes.

Stifel and Cowen and Company are acting as joint book-runners for the offering. Wedbush PacGrow Life Sciences and Roth Capital Partners are acting as co-managers.

The securities described above are being offered pursuant to a "shelf" registration statement previously filed and declared effective by the Securities and Exchange Commission (SEC). The offering is being made only by means of a prospectus supplement and accompanying base prospectus. When available, copies of the final prospectus supplement and accompanying base prospectus relating to the offering may be obtained from Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, or by
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 OticPharma, Ltd., a privately ... for ear, nose, and throat (ENT) disorders, today announced ... complex to be the location of its new U.S. ... of September and will have office locations in both ... OticPharma, Inc. 19900 MacArthur Blvd., Suite 550 ...
(Date:9/2/2015)... , Sept. 2, 2015 This report ... the current and future prospects of the global ... health and assists medical practitioners in deciding the ... progression during treatment. Multi-parameter patient monitoring is effective ... disease. Geriatric population is observed to be at ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... is used to treat an unruptured and ruptured ... wall). The treatment is either known as an ... the endovascular coil blocks the blood flow in ... performed under general anaesthesia by an interventional neuroradiologist ...
Breaking Medicine Technology:OticPharma Establishes U.S. Headquarters in Orange County, California 2Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Neuroendovascular Coil Market 2015-2019 2
... Sept. 19 Immtech Pharmaceuticals,Inc. (Amex: ... Food and Drug Administration,(FDA) has granted Orphan ... African Trypanosomiasis (HAT), also known as African,sleeping ... numerous,financial and regulatory benefits during pafuramidine,s development,including ...
... Both Cultures and Spores of the ... CHICAGO, Sept. 19 Targanta Therapeutics Corporation,today released ... activity of its,lead antibiotic drug candidate, oritavancin, to ... are being presented today,at the 47th Annual Interscience ...
Cached Medicine Technology:US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness 2US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness 3Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria 2Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria 3
(Date:9/3/2015)... ... 2015 , ... Global Vision , the world leader in the development ... print and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... London, booth #F33 , Be the first to get a sneak peek of Intelligent ...
(Date:9/3/2015)... ... September 03, 2015 , ... Hunters Creek Retrievers ... Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited Free ... friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... A scar is an unavoidable result of ... near-miraculous example of the body's ability to heal itself. The appearance of a scar is ... the individual's age, genes, and skin pigmentation. ”Many scars fade to near invisibility on their ...
(Date:9/3/2015)... ... 03, 2015 , ... Representatives with State Farm Agent EJ ... Mississippi Gulf Babypalooza on September 19, 2015. , “We will be providing information ... beyond. We will be discussing setting up college funds, offering information specific to ...
(Date:9/3/2015)... Santa Rosa, CA (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases ... annually. One in seven men will be diagnosed with prostate cancer during their lifetime. While ... increases to six of every 10 men by age 65, according to the American ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... YORK The Max Cure Foundation and the Samuel Waxman Cancer ... cancer research. With that goal in mind, the two Foundations ... G. Van Meir, Ph.D., of Emory University School of Medicine ... using a small molecule that will target the Ewing sarcoma ...
... July 1 issue of the journal SLEEP shows that ... vigor, fatigue and mood in collegiate basketball players. The ... the athletic performance of actively competing athletes. Results ... time per night during sleep extension was 110.9 minutes ...
... awarded $2.4 million to Allina Hospitals & Clinics to ... pain management for patients at Abbott Northwestern Hospital in ... Health and Healing and the Center for Healthcare Innovation ... study. "Integrative medicine emphasizes a full range of ...
... the Salk Institute for Biological Studies have found clues to ... The protein, p53, can cause cells to stop dividing or ... damage, and it is responsible for much of the tissue ... such as the ones commonly used for cancer therapy. The ...
... the foot just before ground contact during running and walking ... a new study published by a University of Georgia kinesiology ... the June online edition of the American Journal of ... of repetitive ankle sprains demonstrated lower clearance heights between their ...
... June 30 (HealthDay News) -- Women diagnosed with breast cancer ... rates than women who just have breast cancer, according to ... cancer but no chronic illness, those who had conditions such ... or lower survival rate, the study authors reported in the ...
Cached Medicine News:Health News:Targeting the Ewing sarcoma family of tumors 2Health News:Extended sleep improves the athletic performance of collegiate basketball players 2Health News:Extended sleep improves the athletic performance of collegiate basketball players 3Health News:Allina receives NIH grant to study real world usage of integrative therapies 2Health News:The genome guardian's dimmer switch: Regulating p53 is a matter of life or death 2Health News:The genome guardian's dimmer switch: Regulating p53 is a matter of life or death 3Health News:Foot positioning during walking and running may influence ankle sprains 2Health News:Breast Cancer Plus Other Health Issues Linked to Worse Outcomes 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: